165 related articles for article (PubMed ID: 14674902)
1. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity.
Dawe RS; Ibbotson SH; Sanderson JB; Thomson EM; Ferguson J
Br J Dermatol; 2003 Dec; 149(6):1232-41. PubMed ID: 14674902
[TBL] [Abstract][Full Text] [Related]
2. Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin.
Dawe RS; Ferguson J; Ibbotson S; Lawrence L; Paulson S; Duffy E; Cammarata S
Photochem Photobiol Sci; 2018 Jun; 17(6):773-780. PubMed ID: 29721574
[TBL] [Abstract][Full Text] [Related]
3. Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice.
Shimoda K; Ikeda T; Okawara S; Kato M
Toxicol Sci; 2000 Aug; 56(2):290-6. PubMed ID: 10910986
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag (75 mg) does not induce photosensitivity: results of a clinical pharmacology trial.
Bowen CJ; Lobb KM; Park JW; Sanderson B; Ferguson J
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):243-9. PubMed ID: 20831698
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity.
Traynor NJ; Barratt MD; Lovell WW; Ferguson J; Gibbs NK
Toxicol In Vitro; 2000 Jun; 14(3):275-83. PubMed ID: 10806378
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers.
Man I; Murphy J; Ferguson J
J Antimicrob Chemother; 1999 May; 43 Suppl B():77-82. PubMed ID: 10382879
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin.
Vousden M; Ferguson J; Richards J; Bird N; Allen A
Chemotherapy; 1999; 45(6):512-20. PubMed ID: 10567783
[TBL] [Abstract][Full Text] [Related]
8. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
[TBL] [Abstract][Full Text] [Related]
9. A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection.
Li Y; Yin Y; Peng X; Zheng H; Fu F; Liu Z; Wu X; Wu X; Zheng S; Chen N; He L; Ren L; Ni Z; Li D; Liang P; Lv X; Zhang Y
Ann Med; 2021 Dec; 53(1):217-226. PubMed ID: 33331182
[TBL] [Abstract][Full Text] [Related]
10. Photoreaction potential of orally administered levofloxacin in healthy subjects.
Boccumini LE; Fowler CL; Campbell TA; Puertolas LF; Kaidbey KH
Ann Pharmacother; 2000 Apr; 34(4):453-8. PubMed ID: 10772429
[TBL] [Abstract][Full Text] [Related]
11. Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation.
Yabe K; Goto K; Jindo T; Sekiguchi M; Furuhama K
Toxicol Lett; 2005 Jul; 157(3):203-10. PubMed ID: 15917145
[TBL] [Abstract][Full Text] [Related]
12. Comparative grepafloxacin phototoxicity in mouse skin.
Owen K
J Antimicrob Chemother; 1998 Aug; 42(2):261-4. PubMed ID: 9738848
[TBL] [Abstract][Full Text] [Related]
13. The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/ tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers.
Murray J; Potts A
J Drugs Dermatol; 2014 Jan; 13(1):16-22. PubMed ID: 24385115
[TBL] [Abstract][Full Text] [Related]
14. Latest industry information on the safety profile of levofloxacin in Japan.
Yagawa K
Chemotherapy; 2001; 47 Suppl 3():38-43; discussion 44-8. PubMed ID: 11549788
[TBL] [Abstract][Full Text] [Related]
15. Comparison of side effects of levofloxacin versus other fluoroquinolones.
Carbon C
Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
[TBL] [Abstract][Full Text] [Related]
16. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin.
Ferguson J; Dawe R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():93-8. PubMed ID: 9484878
[TBL] [Abstract][Full Text] [Related]
17. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice.
Shimoda K; Yoshida M; Wagai N; Takayama S; Kato M
Toxicol Pathol; 1993; 21(6):554-61. PubMed ID: 8052802
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Kim J; Ohtani H; Tsujimoto M; Sawada Y
Drug Metab Pharmacokinet; 2009; 24(2):167-74. PubMed ID: 19430173
[TBL] [Abstract][Full Text] [Related]
19. Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources.
Tokura Y; Iwamoto Y; Mizutani K; Takigawa M
Arch Dermatol Res; 1996; 288(1):45-50. PubMed ID: 8750934
[TBL] [Abstract][Full Text] [Related]
20. In vitro method for prediction of the phototoxic potentials of fluoroquinolones.
Yamamoto T; Tsurumaki Y; Takei M; Hosaka M; Oomori Y
Toxicol In Vitro; 2001 Dec; 15(6):721-7. PubMed ID: 11698174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
